Among the various biomarkers in development to predict clinical changes in CF, we have discussed herein the assessments of extracellular vesicles (EVs) as a robust source of biomarkers and the identification of microRNAs related to CFTR regulation and CF inflammation. This evidence concerns the gene CFTR and cystic fibrosis.